TRANSCRIPTOME OF DNA REPAIR GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA: IDENTIFICATION AND VALIDATION OF NEW THERAPEUTIC TARGETS OF SYNTHETIC LETHALITY

Autor: Hurtado, AM, Gil, GL, Liang, THC, Palomo, L, Lumbreras, E, Caparros, E, Przychodzen, B, Amigo, ML, Campelo, MD, Salido, E, Zamora, L, Ortuno, F, Vicente, V, Maciejewski, J, Del Canizo, C, Sole, F, Marin, FF, Jerez, A

Publikováno v: Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::51ed74a55189be1393fc5af5352f5c76
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6565

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.

Autor: Kiladjian JJ; CIC 1427, Inserm, Université Paris Cité, 75010, Paris, France. jean-jacques.kiladjian@aphp.fr.; Centre d'Investigations Cliniques, AP-HP, Hôpital Saint-Louis, Paris, 75010, France. jean-jacques.kiladjian@aphp.fr., Marin FF; Morales Meseguer University General Hospital, Regional Center of Blood Donation. CIBERER. UCAM. IMIB-Murcia, Murcia, Spain., Al-Ali HK; University Hospital Halle (Saale), Krukenberg Cancer Center Halle, Halle, Germany., Alvarez-Larrán A; Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain., Beggiato E; University Hospital City of Health and Science of Turin - Hospital Molinette, Complex Structure of Hematology, Torino, Italy., Bieniaszewska M; Medical University of Gdańsk, Gdańsk, Poland., Breccia M; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Buxhofer-Ausch V; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Elisabethinen, Johannes Kepler University Linz, Linz, Austria.; Medical Faculty, Johannes Kepler University Linz, Linz, Austria., Cerna O; Clinic of Internal Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic., Crisan AM; Fundeni Clinical Institute, Center for Hematology and Bone Marrow Transplantation, București, Romania., Danaila CD; Department of Clinical Hematology, Regional Institute of Oncology, Iasi, Romania., De Stefano V; Fondazione Policlinico Gemelli IRCCS, Section of Hematology, Catholic University, Rome, Italy., Döhner K; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Empson V; AOP Health, Vienna, Austria., Gora-Tybor J; Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Poland.; Department of Hematology, Medical University of Lodz, Lodz, Poland., Griesshammer M; Department of Oncology and Hematology, Ruhr University Bochum, Johannes Wesling Hospital Minden, Minden, Germany., Grosicki S; Medical University of Silesia, Katowice, Poland., Guglielmelli P; Department of Hematology, Careggi University Hospital, Florence, Italy., García-Gutierrez V; Hospital Universitario Ramón y Cajal, Madrid (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain., Heidel FH; Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany., Illés A; Faculty of Medicine, Department of Internal Medicine, Division of Hematology, University of Debrecen, Debrecen, Hungary., Tomuleasa C; Ion Chiricuta Institute of Oncology, Hematology Department and Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., James C; University Bordeaux, INSERM, BMC, U1034, F-33600, Pessac, France.; Laboratory of Hematology, Bordeaux University Hospital, Bordeaux, France., Koschmieder S; Faculty of Medicine, Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation (Medical Clinic IV), RWTH Aachen University, Aachen, Germany., Krauth MT; Department of Internal Medicine I, Clinical Department of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Krejcy K; AOP Health, Vienna, Austria., Lazaroiu MC; Department of Hematology, Policlinica de Diagnostic Rapid Brasov, Brasov, Romania., Mayer J; University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Masaryk University, Brno, Czech Republic., Nagy ZG; Department of Internal Medicine and Hematology, Division of Hematology, Semmelweis University, Budapest, Hungary., Nicolini FE; Centre Léon Bérard, Lyon, France., Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna and Istituto di Ematologia Seràgnoli, Bologna, Italy., Pappa V; University General Hospital Attikon, Athens, Greece., Reiter AJ; Medical Clinic III, Hematology and Internistic Oncology, University Hospital Mannheim, Mannheim, Germany., Sacha T; Department of Hematology, Jagiellonian University Hospital, Kraków, Poland., Schlager S; AOP Health, Vienna, Austria., Schmidt S; Department of Internal Medicine V (Hematology and Oncology), Medical University Innsbruck, Innsbruck, Austria., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Unger M; AOP Health, Vienna, Austria., Wölfler A; Department of Internal Medicine, Clinical Divison of Hematology, Medical University Graz, Graz, Austria., Cirici BX; Institut Català d' Oncologia- Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Klade C; AOP Health, Vienna, Austria.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2299-2310. Date of Electronic Publication: 2024 Mar 04.